P. Engblom

Mutations of TP53 do not correlate with the sensitivity to paclitaxel--a study using 27 gynaecological cancer cell lines.

V. Rantanen, S. Grénman, S. Syrjänen, 2002, European journal of cancer.

Additive and supra-additive cytotoxicity of cisplatin-taxane combinations in ovarian carcinoma cell lines

V. Rantanen, S. Grénman, H. Helenius, 1999, British Journal of Cancer.

Carboplatin–paclitaxel‐ and carboplatin–docetaxel‐induced cytotoxic effect in epithelial ovarian carcinoma in vitro

V. Rantanen, S. Grénman, J. Kulmala, 1999, Cancer.

Effects of paclitaxel with or without cremophor EL on cellular clonogenic survival and apoptosis.

V. Rantanen, S. Grénman, R. Grenman, 1999, European journal of cancer.

Taxane sensitivity of ovarian carcinoma in vitro.

V. Rantanen, S. Grénman, J. Heiskanen, 1997, Anticancer research.